Gian Lifecare Ltd

Gian Lifecare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Gian Lifecare Ltd

₹ 6.21 -1.27%
27 Mar - close price
gianpathlabs.com BSE: 542918
About

Incorporated in 2018, Gian Lifecare Ltd is in the business of independent diagnostic/pathological laboratories[1]

Key Points

Business Overview:[1]
GLL provides diagnostic and healthcare testing services across Kanpur and nearby cities. It offers patient diagnosis, prevention, and wellness services to individuals and healthcare providers. The company is expanding its network with new diagnostic labs nationwide. In addition to its major lab in Kanpur, its Lucknow lab became fully operational in FY23.

Website BSE
  • Market Cap ₹ 6.42 Cr.
  • Current Price ₹ 6.21
  • High / Low ₹ 18.7 / 5.96
  • Stock P/E
  • Book Value ₹ 18.7
  • Dividend Yield 0.00 %
  • ROCE 3.00 %
  • ROE 0.81 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.33 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -4.07% over past five years.
  • Promoter holding is low: 32.1%
  • Company has a low return on equity of 11.0% over last 3 years.
  • Promoters have pledged 61.2% of their holding.
  • Company has high debtors of 374 days.
  • Promoter holding has decreased over last 3 years: -28.6%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
5.09 1.55 2.43 2.30 3.79 4.60 1.98 1.95 1.59 1.11 0.87 0.66 1.12
2.80 2.27 1.92 1.97 1.55 1.49 1.76 1.72 1.11 1.12 0.73 1.05 0.87
Operating Profit 2.29 -0.72 0.51 0.33 2.24 3.11 0.22 0.23 0.48 -0.01 0.14 -0.39 0.25
OPM % 44.99% -46.45% 20.99% 14.35% 59.10% 67.61% 11.11% 11.79% 30.19% -0.90% 16.09% -59.09% 22.32%
0.17 0.18 0.14 0.15 0.16 0.18 0.17 0.16 0.16 -0.24 0.15 0.09 0.09
Interest 0.12 0.11 0.12 0.11 0.11 0.11 0.11 0.10 0.10 0.10 0.09 0.09 0.13
Depreciation 0.14 0.12 0.13 0.13 0.13 0.07 0.12 0.12 0.12 0.11 0.11 0.11 0.11
Profit before tax 2.20 -0.77 0.40 0.24 2.16 3.11 0.16 0.17 0.42 -0.46 0.09 -0.50 0.10
Tax % 13.64% 18.18% 35.00% 16.67% 24.54% 29.26% 37.50% 11.76% 9.52% 4.35% 33.33% -8.00% -30.00%
1.89 -0.90 0.26 0.20 1.63 2.20 0.11 0.14 0.38 -0.48 0.05 -0.46 0.12
EPS in Rs 1.83 -0.87 0.25 0.19 1.58 2.13 0.11 0.14 0.37 -0.46 0.05 -0.44 0.12
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 5m Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0.56 7.31 10.24 15.45 11.41 12.78 5.94 3.76
0.36 5.23 7.14 9.39 9.37 6.58 4.99 3.77
Operating Profit 0.20 2.08 3.10 6.06 2.04 6.20 0.95 -0.01
OPM % 35.71% 28.45% 30.27% 39.22% 17.88% 48.51% 15.99% -0.27%
0.00 0.10 0.29 0.51 0.69 0.64 0.25 0.09
Interest 0.04 0.37 0.35 0.39 0.45 0.47 0.43 0.41
Depreciation 0.02 0.26 0.29 0.33 0.50 0.46 0.47 0.44
Profit before tax 0.14 1.55 2.75 5.85 1.78 5.91 0.30 -0.77
Tax % 21.43% 28.39% 26.91% 25.30% 29.78% 27.24% 46.67%
0.10 1.13 2.02 4.37 1.26 4.30 0.16 -0.77
EPS in Rs 1.10 1.96 4.23 1.22 4.16 0.15 -0.73
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: -4%
3 Years: -27%
TTM: -63%
Compounded Profit Growth
10 Years: %
5 Years: -32%
3 Years: -67%
TTM: -127%
Stock Price CAGR
10 Years: %
5 Years: 0%
3 Years: -30%
1 Year: -64%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 11%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.01 4.70 4.70 10.34 10.34 10.34 10.34 10.34
Reserves 0.10 2.94 4.96 3.69 4.97 9.27 9.42 9.01
1.36 1.09 1.00 2.03 4.57 4.17 5.07 4.90
6.34 3.64 4.82 7.00 8.52 8.28 10.73 9.52
Total Liabilities 7.81 12.37 15.48 23.06 28.40 32.06 35.56 33.77
2.91 2.84 2.99 3.50 4.62 4.47 4.01 3.78
CWIP 0.00 0.00 0.00 0.12 0.14 0.14 0.14 0.14
Investments 0.00 0.00 0.00 0.11 0.11 0.11 0.11 0.11
4.90 9.53 12.49 19.33 23.53 27.34 31.30 29.74
Total Assets 7.81 12.37 15.48 23.06 28.40 32.06 35.56 33.77

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2.99 1.51 2.87 5.79 2.32 0.75 0.25
-2.92 -3.96 -1.10 -4.23 -0.94 0.33 0.23
0.96 2.55 -0.39 0.67 -0.37 -0.86 0.49
Net Cash Flow 1.03 0.10 1.38 2.23 1.01 0.22 0.97
Free Cash Flow 0.06 1.32 2.44 4.83 0.69 0.44 0.24
CFO/OP 1,495% 84% 102% 107% 115% 12% 29%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 860.36 78.39 73.07 42.05 103.97 137.37 374.22
Inventory Days 4,380.00
Days Payable 5,266.43
Cash Conversion Cycle -26.07 78.39 73.07 42.05 103.97 137.37 374.22
Working Capital Days -2,887.41 -42.44 -53.82 -31.42 -160.27 -68.83 -46.70
ROCE % 37.65% 31.98% 46.71% 12.41% 29.23% 3.00%

Insights

In beta
Sep 2021 Mar 2023 Mar 2024 Mar 2025
Number of Employees
Number

Log in to view insights

Please log in to see hidden values.

Login
Number of Laboratories
Number
Investment in Laboratories
Lac
Laboratory Space
Sq Ft
Test Menu Size
Number
Number of Tests Performed
Lac

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
56.90% 53.10% 53.10% 51.73% 48.47% 32.82% 31.99% 32.09% 32.09% 32.09% 32.09% 32.09%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01% 0.01% 0.01% 0.01%
43.10% 46.90% 46.90% 48.26% 51.53% 67.18% 68.01% 67.91% 67.90% 67.89% 67.91% 67.89%
No. of Shareholders 1,0891,3362,0982,0922,4263,3493,8634,2984,3824,3634,2854,217

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Nov 2021
    Transcript
    AI Summary
    PPT